Menu

Pick your frog poison

Human development may destroy natural habitats, but it could also provide amphibians with a safe haven from deadly fungal infections.

May 31, 2011
Jessica P. Johnson

Extinct Monteverde golden toadIMAGE: WIKIMEDIA COMMONS, US FISH AND WILDLIFE SERVICEAmphibians that inhabit natural environments are more likely to be infected with the fatal Bd fungus that has devastated frog and salamander populations worldwide than those living in habitats disturbed by human development.

The results, published yesterday (May 30) in the Proceedings of the National Academy of Sciences, challenge the assumption that habitat loss necessarily exacerbates the spread of disease.

"I don't think anyone will be going up in the mountains cutting down trees in the hopes of getting rid of Bd or anything," said Forrest Brem who researches amphibian epidemiology at the University of Memphis and was not involved in the research. "But I think this study will remind everyone how complex host-pathogen-environment systems are and encourage us to incorporate this complexity in their thinking, teaching, and research."

Bd (Batrachochytrium dendrobatidis) is a member of the chytrid fungus family, which attacks some 350 amphibian species. In the last 15 years, it has caused massive declines of amphibian populations around the world, even driving some species to extinction. The fungus, spread by skin-to-skin contact or through the water, kills by causing the outer layer of skin to thicken and become less permeable to the water-borne electrolytes amphibians absorb to keep their hearts beating. And for those amphibians that absorb oxygen through their skin, a Bd infection suffocates them.

Since the international trade of amphibians as food, pets, and lab animals took off in the 1970s, Bd has passed to every continent that supports amphibian species. "It's spreading like a wave," said C. Guilherme Becker, a graduate student in ecology and evolutionary biology at Cornell University and lead author on the study. "Especially in Central America and Australia."

In addition to the spread of Bd, amphibians across the globe are suffering from loss of habitat caused by human development. The combination of the disease and habitat loss is a "double threat," said Becker, and implementing successful future conservation efforts requires an understanding of interactions between these two forces.

To this end, he and his advisor, Kelly Zamudio, compared habitat loss and Bd infection data from tropical sites in Costa Rica (for the common rain frog) and in eastern Australia (for the Stony Creek frog). In contrast to past studies of other human and animal diseases, they found that the frogs in disturbed habitats were less likely to be infected. Field surveys of disturbed and natural habitats of the golden lesser tree frog in the Brazilian Atlantic Forest confirmed these findings.

Despite many studies showing that habitat disturbance increases disease in human and animal populations, in the case of Bd "it is not surprising that disease risk is higher in more natural habitats," Ross Alford, professor of tropical ecology at James Cook University in Australia who did not participate in the research, said in an email to The Scientist. Bd is very intolerant of the hot, dry environments that often result from habitat disturbance, he explained. Furthermore, natural environments support a greater number of hosts that could help spread the fungus, added Becker.

The three species studied, however, are habitat generalists that are relatively tolerant to human disturbance. But other species are not so hardy, and will either suffer from the changing habitat itself, or retreat to natural habitats, where Bd is more prevalent. "Disturbed habitats may act as shelters from disease, but only for the very few species that can tolerate deforestation," Becker and Zamudio wrote in their paper.

"This study contributes to our understanding of the interactions [of Bd with amphibians] and may well aid in thinking 'outside the box' in developing management tools," said Alford.

C.G. Becker and K.R. Zamudio, "Tropical amphibian populations experience higher disease risk in natural habitats," PNAS, doi: 10.1073/pnas.1014497108, 2011.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.